Organ-on-Chip In the Organ-on-Chip group, we are engaged in the development and qualification of Organ-on-Chip (OoC) systems and enabler technologies, as well as the application of OoC models for basi

Tribology Dr. Tarek Lutz Group Leader Center for Nanoanalytics +49 7121 51530-900 E-Mail anzeigen Friction and wear are tribological problems, for the solution of which the NanoZ uses its interfacial

The certificate from the German Accreditation Body has just arrived at the NMI. This means that the testing spectrum at the institute has now been extended by two methods. The certificate from the Ger

More information on MagBatt V here .

BioDevCenter - Biologicals Development Center Dr. rer. nat. Thomas Joos Deputy Director of the Institute +49 7121 51530-844 E-Mail anzeigen Dr. Anne Zeck Group Leader Bioanalytics +49 7121 51530-811 E

Precision oncology presents practitioners with the challenge of adapting and interpreting clinical and imaging data, histological and molecular pathology results and genetic analyses to the individual

The search for neuroactive substances that can be used therapeutically is accompanied by a high rate of exclusion of drug candidates. The new test platform is intended to help reduce this exclusion ra

Identification of new target proteins for pancreatic carcinoma Early stages of pancreatic tumors often cause no symptoms, while later-stage symptoms are often nonspecific. Pancreatic cancer is therefo

ERA-Net Eurotransbio: Models for Alzheimer's and similar diseases, drug development based on the mitochondrial cascade hypothesis Mitochondria are the powerhouses of cells. Recent investigations sugge

Identifizierung von Biomarkern zur Vorhersage des Ansprechens und der Resistenz gegenüber VEGFR/mTOR-Inhibitoren beim Nierenkarzinom